Published in TB and Outbreaks Week, September 24th, 2002
Halvor Rollag and colleagues working at the University of Oslo Hospital evaluated the prognostic value of three CMV blood tests for kidney transplant patients.
The quantitative DNA test provided the most useful results, Rollag and coauthors found.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.